Cerus Corporation
US ˙ NasdaqGM ˙ US1570851014

Introduktion

Denne side giver en omfattende analyse af den kendte insiderhandelshistorie for Daniel N JR Swisher. Insidere er embedsmænd, direktører eller betydelige investorer i en virksomhed. Det er ulovligt for insidere at foretage handler i deres virksomheder baseret på specifik, ikke-offentlig information. Dette betyder ikke, at det er ulovligt for dem at handle i deres egne virksomheder. De skal dog rapportere alle handler til SEC via en formular 4. På trods af disse begrænsninger tyder akademisk forskning på, at insidere - generelt - har en tendens til at klare sig bedre end markedet i deres egne virksomheder.

Gennemsnitlig handelsrentabilitet

Den gennemsnitlige handelsrentabilitet er det gennemsnitlige afkast af alle køb på det åbne marked foretaget af insideren i de sidste tre år. For at beregne dette undersøger vi ethvert åbent marked, uplanlagte køb foretaget af insideren, eksklusive alle handler, der var markeret som en del af en 10b5-1-handelsplan. Vi beregner derefter den gennemsnitlige præstation for disse handler over 3, 6 og 12 måneder, idet vi tager et gennemsnit af hver af disse varigheder for at generere en endelig præstationsmåling for hver handel. Endelig tager vi et gennemsnit af alle præstationsmålingerne for at beregne en præstationsmåling for insideren. Denne liste inkluderer kun insidere, der har foretaget mindst tre handler i de sidste to år.

Hvis denne insiderhandelsrentabilitet er "N/A", så har insideren enten ikke foretaget nogen køb på det åbne marked i de sidste tre år, eller de handler, de har foretaget, er for nye til at beregne en pålidelig præstationsmåling.

Opdateringsfrekvens: Dagligt

Se listen over de mest profitable insiderhandlere.

Virksomheder med rapporterede insider-stillinger

SEC-registreringen viser, at Daniel N JR Swisher har rapporteret besiddelser eller handler i følgende virksomheder:

Sikkerhed Titel Senest indberettede beholdninger
US:CORT / Corcept Therapeutics Incorporated Director 0
US:CERS / Cerus Corporation Director 207.045
US:JAZZ / Jazz Pharmaceuticals plc President and COO 55.014
President and CEO, Director 240.177
Sådan fortolkes diagrammerne

Følgende diagrammer viser aktieudviklingen for værdipapirer efter hver åben-marked, ikke-planlagt handel foretaget af Daniel N JR Swisher. Ikke-planlagt handel er handler, der ikke blev foretaget som en del af en 10b5-1-handelsplan. Aktieudviklingen er kortlagt som den kumulative procentvise ændring i aktiekursen. For eksempel, hvis en insiderhandel blev foretaget den 1. januar 2019, vil diagrammet vise den daglige procentvise ændring af værdipapiret til i dag. Hvis aktiekursen skulle gå fra $10 til $15 i løbet af denne tid, ville den kumulative procentvise ændring i aktiekursen være 50%. En prisændring fra 10 USD til 20 USD ville være 100 %, og en ændring i prisen på 10 USD til 5 USD ville være -50 %.

I sidste ende forsøger vi at bestemme, hvor tæt insiderens handler korrelerer med merafkast (positive eller negative) i aktiekursen for at se, om insideren timing deres handler til at drage fordel af insiderinformation. Overvej situationen, hvor en insider gjorde dette. I denne situation ville vi forvente enten (a) positive afkast efter køb eller (b) negative afkast efter salg. I tilfælde af (a) vil KØB-diagrammet vise en række opadskrånende kurver, der indikerer positive afkast efter hver købstransaktion. I tilfælde af (b) vil SALE-diagrammet vise en række nedadgående kurver, der indikerer negative afkast efter hver salgstransaktion.

Dette alene er dog ikke nok til at drage konklusioner. Hvis for eksempel aktiekursen i selskabet var i en ikke-cyklisk stigning over mange år, så ville vi forvente, at alle efterkøbsgrundene var opadgående. Ligeledes ville ikke-cykliske fald over mange år resultere i nedadgående post-trade plots. Ingen af disse diagrammer tyder på insiderhandel.

Den stærkeste indikator ville være en situation, hvor aktiekursen var ekstremt cyklisk, og der var både positive signaler i KØB-diagrammet og negative plots på SALG-diagrammet. Denne situation ville i høj grad tyde på en insider, der havde timing af handler til deres økonomiske fordel.

Insiderkøb CERS / Cerus Corporation – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CERS / Cerus Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
2024-05-09 CERS Swisher Daniel N JR 2.500 1,8755 2.500 1,8755 4.689 68 2.3900 1.287 27,45
2023-05-26 CERS Swisher Daniel N JR 5.000 1,9070 5.000 1,9070 9.535
2020-01-29 CERS Swisher Daniel N JR 1.000 4,1500 1.000 4,1500 4.150

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CERS / Cerus Corporation Insider Trades
Insidersalg CERS / Cerus Corporation – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CERS / Cerus Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2022-11-10 CERS Swisher Daniel N JR 12.500 3,9100 12.500 3,9100 48.875 343 1.2500 -33.250 -68,03
2020-11-17 CERS Swisher Daniel N JR 10.000 6,2505 10.000 6,2505 62.505

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CERS / Cerus Corporation Insider Trades
Insiderkøb CORT / Corcept Therapeutics Incorporated – kortsigtet profitanalyse

I dette afsnit analyserer vi rentabiliteten af ethvert uplanlagt insiderkøb i åbent marked foretaget i CERS / Cerus Corporation. Denne analyse hjælper med at forstå, om insideren konsekvent genererer unormale afkast og er værd at følge. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste køb på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Maks
Pris kl
Maks
Maks
Fortjeneste ($)
Maks. afkast (%)
Der er ingen kendte uplanlagte åbne markedshandler for denne insider- og sikkerhedskombination

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CORT / Corcept Therapeutics Incorporated Insider Trades
Insidersalg CORT / Corcept Therapeutics Incorporated – kortsigtet tabsanalyse

I dette afsnit analyserer vi den kortsigtede undgåelse af tab af ethvert uplanlagt insidersalg på åbent marked, der foretages i CERS / Cerus Corporation. Et konsekvent mønster af tabsforebyggelse kan tyde på, at fremtidige salgstransaktioner kan forudsige prisfald. Denne analyse er for et år efter hver handel, og resultaterne er teoretiske .

Følgende tabel viser de seneste salg på det åbne marked, der ikke var en del af en automatisk handelsplan.

Handelsdato Ticker Insider Rapporteret
Aktier
Rapporteret
Pris
Justeret
Aktier
Justeret
Pris
Omkostningsgrundlag dage til
Min
Pris kl
Min
Max tab
Undgået ($)
Max tab
Undgået (%)
2023-09-05 CORT Swisher Daniel N JR 2.200 32,9000 2.200 32,9000 72.380 148 21.1000 -25.960 -35,87
2023-09-01 CORT Swisher Daniel N JR 1.550 32,7300 1.550 32,7300 50.732
2023-08-07 CORT Swisher Daniel N JR 2.200 30,1400 2.200 30,1400 66.308
2023-08-07 CORT Swisher Daniel N JR 650 30,1550 650 30,1550 19.601
2022-08-08 CORT Swisher Daniel N JR 15.385 28,3200 15.385 28,3200 435.703

Justeret pris er den split-justerede pris. Adjusted Shares er de split-justerede aktier.

CORT / Corcept Therapeutics Incorporated Insider Trades
Insiderhandelshistorie

Denne tabel viser den komplette liste over insiderhandler foretaget af Daniel N JR Swisher som oplyst til Securities Exchange Commission (SEC).

Fil dato Transdato Form Ticker Sikkerhed Kode 10b5-1 Aktier Resterende aktier Procent
Lave om
Del
Pris
Tran
Værdi
Tilbage
Værdi
2025-09-11 2025-09-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 72,45 -159.390
2025-09-11 2025-09-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 14,08 30.976 30.976
2025-08-12 2025-08-11 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 72,30 -159.060
2025-08-12 2025-08-11 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 14,08 30.976 30.976
2025-07-14 2025-07-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 71,08 -156.376
2025-07-14 2025-07-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 14,08 30.976 30.976
2025-06-12 2025-06-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 70,61 -155.342
2025-06-12 2025-06-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 14,08 30.976 30.976
2025-06-04 2025-06-03 4 CERS CERUS CORP
Common Stock
A - Award 60.000 207.045 40,80
2025-05-14 2025-05-12 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -400 0 -100,00 71,55 -28.620
2025-05-14 2025-05-12 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -1.800 400 -81,82 72,17 -129.906 28.868
2025-05-14 2025-05-12 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 400 2.200 22,22 14,08 5.632 30.976
2025-05-14 2025-05-12 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 1.800 1.800 12,13 21.834 21.834
2025-04-14 2025-04-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 70,22 -154.484
2025-04-14 2025-04-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 12,13 26.686 26.686
2025-03-12 2025-03-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 53,60 -117.920
2025-03-12 2025-03-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 12,13 26.686 26.686
2025-02-12 2025-02-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 68,08 -149.776
2025-02-12 2025-02-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 12,13 26.686 26.686
2025-01-14 2025-01-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 50,54 -111.188
2025-01-14 2025-01-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 12,13 26.686 26.686
2024-12-12 2024-12-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 59,46 -130.812
2024-12-12 2024-12-10 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 12,13 26.686 26.686
2024-11-13 2024-11-11 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 59,88 -131.736
2024-11-13 2024-11-11 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 12,13 26.686 26.686
2024-08-05 2024-08-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -150 0 -100,00 38,50 -5.775
2024-08-05 2024-08-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 150 150 5,86 879 879
2024-07-03 2024-07-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 32,81 -72.182
2024-07-03 2024-07-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2024-06-06 2024-06-05 4 CERS CERUS CORP
Common Stock
A - Award 40.000 147.045 37,37 5,00 200.000 735.225
2024-06-05 2024-06-03 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 30,21 -66.462
2024-06-05 2024-06-03 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2024-05-09 2024-05-09 4 CERS CERUS CORP
Common Stock
P - Purchase 2.500 107.045 2,39 1,88 4.689 200.763
2024-05-03 2024-05-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 23,09 -50.798
2024-05-03 2024-05-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2024-04-03 2024-04-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 25,30 -55.660
2024-04-03 2024-04-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2024-03-05 2024-03-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 23,59 -51.898
2024-03-05 2024-03-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2024-02-02 2024-02-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 22,00 -48.400
2024-02-02 2024-02-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2024-01-04 2024-01-02 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 22,11 -48.642
2024-01-04 2024-01-02 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2023-12-05 2023-12-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 25,47 -56.034
2023-12-05 2023-12-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2023-11-03 2023-11-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 27,96 -61.512
2023-11-03 2023-11-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2023-10-04 2023-10-02 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -2.200 0 -100,00 27,32 -60.104
2023-10-04 2023-10-02 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2023-09-06 2023-09-05 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale -2.200 0 -100,00 32,90 -72.380
2023-09-06 2023-09-05 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 5,86 12.892 12.892
2023-09-06 2023-09-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale -1.550 0 -100,00 32,73 -50.732
2023-09-06 2023-09-01 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 1.550 1.550 6,55 10.152 10.152
2023-08-09 2023-08-07 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale -650 0 -100,00 30,16 -19.601
2023-08-09 2023-08-07 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale -2.200 650 -77,19 30,14 -66.308 19.591
2023-08-09 2023-08-07 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 650 2.850 29,55 5,86 3.809 16.701
2023-08-09 2023-08-07 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 2.200 2.200 6,55 14.410 14.410
2023-06-09 2023-06-07 4 CERS CERUS CORP
Common Stock
A - Award 40.000 104.545 61,97 5,00 200.000 522.725
2023-05-30 2023-05-26 4 CERS CERUS CORP
Common Stock
P - Purchase 5.000 118.808 4,39 1,91 9.535 226.567
2023-03-07 2023-03-05 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
F - Taxes -5.426 55.014 -8,98 142,78 -774.724 7.854.899
2023-03-07 2023-03-03 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
A - Award 13.456 60.440 28,64
2022-12-07 2022-12-05 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
J - Other -10.465 46.984 -18,22
2022-11-14 2022-11-10 4 CERS CERUS CORP
Common Stock
S - Sale -12.500 113.808 -9,90 3,91 -48.875 444.989
2022-11-14 2022-11-10 4 CERS CERUS CORP
Common Stock
M - Exercise 12.500 126.308 10,98 3,19 39.875 402.923
2022-08-09 2022-08-08 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale -15.385 0 -100,00 28,32 -435.703
2022-08-09 2022-08-08 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
F - Taxes -4.615 15.385 -23,08 28,39 -131.020 436.780
2022-08-09 2022-08-08 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise 20.000 20.000 6,55 131.000 131.000
2022-06-03 2022-06-01 4 CERS CERUS CORP
Common Stock
A - Award 20.454 113.808 21,91
2022-03-09 2022-03-05 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
F - Taxes -4.802 57.251 -7,74 153,96 -739.316 8.814.364
2022-03-09 2022-03-03 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
A - Award 13.507 62.053 27,82
2022-01-05 2022-01-03 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
F - Taxes -1.624 48.546 -3,24 131,01 -212.760 6.360.011
2021-09-03 2021-09-02 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
M - Exercise X -7.500 27.500 -21,43
2021-09-03 2021-09-02 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -7.500 0 -100,00 21,70 -162.741
2021-09-03 2021-09-02 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise X 7.500 7.500 6,55 49.125 49.125
2021-08-05 2021-08-04 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -12.877 0 -100,00
2021-08-05 2021-08-04 4 CERS CERUS CORP
Common Stock
S - Sale X -12.877 93.354 -12,12 6,25 -80.481 583.462
2021-08-05 2021-08-04 4 CERS CERUS CORP
Common Stock
M - Exercise X 12.877 106.231 13,79 2,86 36.828 303.821
2021-06-04 2021-06-02 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
M - Exercise X -7.500 35.000 -17,65
2021-06-04 2021-06-02 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -7.500 0 -100,00 21,48 -161.085
2021-06-04 2021-06-02 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise X 7.500 7.500 6,55 49.125 49.125
2021-06-03 2021-06-02 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 35.295 35.295
2021-06-03 2021-06-02 4 CERS CERUS CORP
Common Stock
A - Award 17.525 93.354 23,11
2021-06-03 2021-06-01 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -15.961 0 -100,00
2021-06-03 2021-06-01 4 CERS CERUS CORP
Common Stock
M - Exercise 15.961 75.829 26,66
2021-05-28 2021-05-26 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
A - Award 20.000 20.000
2021-05-20 2021-05-18 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -5.000 0 -100,00
2021-05-20 2021-05-18 4 CERS CERUS CORP
Common Stock
S - Sale X -5.000 59.868 -7,71 5,75 -28.735 344.061
2021-05-20 2021-05-18 4 CERS CERUS CORP
Common Stock
M - Exercise X 5.000 64.868 8,35 2,90 14.500 188.117
2021-04-07 2021-04-05 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
M - Exercise X -7.500 42.500 -15,00
2021-04-07 2021-04-05 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -7.500 0 -100,00 24,14 -181.036
2021-04-07 2021-04-05 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise X 7.500 7.500 6,55 49.125 49.125
2021-03-09 2021-03-05 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
F - Taxes -3.718 49.961 -6,93 164,75 -612.540 8.231.075
2021-03-01 2021-02-25 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
A - Award 11.695 53.679 27,86
2021-02-18 2021-02-16 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -10.000 5.000 -66,67
2021-02-18 2021-02-16 4 CERS CERUS CORP
Common Stock
S - Sale X -10.000 59.868 -14,31 7,78 -77.797 465.755
2021-02-18 2021-02-16 4 CERS CERUS CORP
Common Stock
M - Exercise X 10.000 69.868 16,70 2,90 29.000 202.617
2021-01-21 2021-01-19 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
M - Exercise X -5.000 50.000 -9,09
2021-01-21 2021-01-19 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -5.000 0 -100,00 28,74 -143.686
2021-01-21 2021-01-19 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise X 5.000 5.000 6,55 32.750 32.750
2021-01-06 2021-01-04 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
F - Taxes -1.607 41.984 -3,69 160,40 -257.763 6.734.234
2020-11-19 2020-11-17 4 CERS CERUS CORP
Option (Right to Buy)
M - Exercise -10.000 15.000 -40,00
2020-11-19 2020-11-17 4 CERS CERUS CORP
Common Stock
S - Sale -10.000 59.868 -14,31 6,25 -62.505 374.205
2020-11-19 2020-11-17 4 CERS CERUS CORP
Common Stock
M - Exercise X 10.000 69.868 16,70 2,90 29.000 202.617
2020-10-21 2020-10-19 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
M - Exercise X -5.000 55.000 -8,33
2020-10-21 2020-10-19 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -5.000 0 -100,00 17,66 -88.301
2020-10-21 2020-10-19 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise X 5.000 5.000 6,55 32.750 32.750
2020-07-20 2020-07-17 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
M - Exercise X -5.000 60.000 -7,69
2020-07-20 2020-07-17 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -5.000 0 -100,00 16,48 -82.411
2020-07-20 2020-07-17 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise X 5.000 5.000 6,55 32.750 32.750
2020-06-09 2020-06-05 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -13.958 0 -100,00
2020-06-09 2020-06-05 4 CERS CERUS CORP
Common Stock
M - Exercise 13.958 59.868 30,40
2020-06-05 2020-06-03 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 15.961 15.961
2020-06-05 2020-06-03 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 34.001 34.001
2020-05-29 2020-05-27 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
A - Award 30.000 30.000
2020-05-27 2020-05-22 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
M - Exercise X -5.000 65.000 -7,14
2020-05-27 2020-05-22 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
S - Sale X -5.000 0 -100,00 16,10 -80.500
2020-05-27 2020-05-22 4 CORT CORCEPT THERAPEUTICS INC
Common Stock
M - Exercise X 5.000 5.000 6,55 32.750 32.750
2020-03-09 2020-03-05 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
F - Taxes -1.735 43.391 -3,84 124,50 -216.008 5.402.180
2020-03-02 2020-02-27 4 JAZZ Jazz Pharmaceuticals plc
Non-Qualified Stock Option (right to buy)
A - Award 39.114 39.114
2020-03-02 2020-02-27 4 JAZZ Jazz Pharmaceuticals plc
Incentive Stock Option (right to buy)
A - Award 886 886
2020-03-02 2020-02-27 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
A - Award 16.000 45.126 54,93
2020-02-06 2020-01-29 4 CERS CERUS CORP
Common Stock
P - Purchase 1.000 45.910 2,23 4,15 4.150 190.526
2020-02-03 2019-06-05 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 13.958 13.958
2020-02-03 2019-06-05 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 29.581 29.581
2020-01-06 2020-01-03 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
D - Sale to Issuer -1.599 29.126 -5,20 146,09 -233.598 4.255.017
2019-06-20 2019-06-18 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
A - Award 25.000 25.000
2019-06-07 2019-06-05 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 13.958 13.958
2019-06-07 2019-06-05 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 29.581 29.581
2019-06-06 2019-06-04 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -12.758 0 -100,00
2019-06-06 2019-06-04 4 CERS CERUS CORP
Common Stock
M - Exercise 12.758 44.910 39,68
2019-03-04 2019-02-28 4 JAZZ Jazz Pharmaceuticals plc
Non-Qualified Stock Option (right to buy)
A - Award 34.286 34.286
2019-03-04 2019-02-28 4 JAZZ Jazz Pharmaceuticals plc
Incentive Stock Option (right to buy)
A - Award 714 714
2019-03-04 2019-02-28 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
A - Award 14.000 30.512 84,79
2019-01-07 2019-01-03 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
F - Taxes -1.604 16.512 -8,85 126,01 -202.120 2.080.677
2018-08-22 2018-08-20 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
A - Award 25.000 25.000
2018-07-11 2018-06-06 4/A CERS CERUS CORP
Restricted Stock Unit
A - Award 12.758 12.758
2018-07-11 2018-06-06 4/A CERS CERUS CORP
Option (Right to Buy)
A - Award 24.014 24.014
2018-06-22 2018-06-06 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 12.758 12.758
2018-06-22 2018-06-06 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 20.466 20.466
2018-06-05 2018-06-05 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -19.816 0 -100,00
2018-06-05 2018-06-05 4 CERS CERUS CORP
Common Stock
M - Exercise 19.816 32.152 160,64
2018-03-05 2018-03-01 4 JAZZ Jazz Pharmaceuticals plc
Non-Qualified Stock Option (right to buy)
A - Award 42.160 42.160
2018-03-05 2018-03-01 4 JAZZ Jazz Pharmaceuticals plc
Incentive Stock Option (right to buy)
A - Award 2.840 2.840
2018-03-05 2018-03-01 4 JAZZ Jazz Pharmaceuticals plc
Ordinary Shares
A - Award 18.000 18.000
2017-07-12 2017-07-10 4 SNSS SUNESIS PHARMACEUTICALS INC
Employee Stock Option(right to buy)
A - Award 240.177 240.177
2017-07-12 2017-07-10 4 SNSS SUNESIS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
A - Award 17.582 17.582
2017-07-12 2017-07-10 4 SNSS SUNESIS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
D - Sale to Issuer -50.000 0 -100,00
2017-07-12 2017-07-10 4 SNSS SUNESIS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
D - Sale to Issuer -50.000 0 -100,00
2017-07-12 2017-07-10 4 SNSS SUNESIS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
D - Sale to Issuer -50.001 0 -100,00
2017-07-12 2017-07-10 4 SNSS SUNESIS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
D - Sale to Issuer -70.834 0 -100,00
2017-07-12 2017-07-10 4 SNSS SUNESIS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
D - Sale to Issuer -118.435 0 -100,00
2017-07-12 2017-07-10 4 SNSS SUNESIS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
D - Sale to Issuer -18.333 0 -100,00
2017-07-12 2017-07-10 4 SNSS SUNESIS PHARMACEUTICALS INC
Employee Stock Option (right to buy)
D - Sale to Issuer -4.306 0 -100,00
2017-06-12 2017-06-07 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 19.816 19.816
2017-06-12 2017-06-07 4 CERS CERUS CORP
Option Right to Buy
A - Award 47.507 47.507
2017-06-12 2017-06-06 4 CERS CERUS CORP
Restricted Stock Unit
M - Exercise -12.366 0 -100,00
2017-06-12 2017-06-06 4 CERS CERUS CORP
Common Stock
M - Exercise 12.336 12.336
2017-05-26 2017-05-24 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
A - Award 30.000 30.000
2016-12-06 2016-11-30 4/A SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 240.000 240.000
2016-12-02 2016-11-30 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 240.000 240.000
2016-07-22 2016-07-21 4 CORT CORCEPT THERAPEUTICS INC
Stock Option (Right to Buy)
A - Award 50.000 50.000
2016-06-10 2016-06-08 4 CERS CERUS CORP
Restricted Stock Unit
A - Award 12.336 12.336
2016-06-10 2016-06-08 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 25.252 25.252
2016-03-02 2016-02-29 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
F - Taxes -55.675 266.519 -17,28 0,75 -41.756 199.889
2016-03-02 2016-02-29 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
A - Award 137.533 322.194 74,48
2015-12-02 2015-11-30 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 660.000 660.000
2015-08-26 2015-08-25 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
P - Purchase 12.216 199.736 6,51 1,01 12.338 201.733
2015-08-26 2015-08-24 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
P - Purchase 12.784 187.520 7,32 1,01 12.912 189.395
2015-07-28 2015-07-24 4 SNSS SUNESIS PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -11.105 0 -100,00
2015-07-28 2015-07-24 4 SNSS SUNESIS PHARMACEUTICALS INC
Warrant (right to buy)
X - Other -22.210 0 -100,00
2015-07-28 2015-07-24 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
P - Purchase 25.000 174.336 16,74 1,02 25.458 177.526
2015-07-28 2015-07-24 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -4.238 149.736 -2,75 3,46 -14.657 517.862
2015-07-28 2015-07-24 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
X - Other 11.105 153.974 7,77 1,32 14.659 203.246
2015-07-28 2015-07-24 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale -8.477 142.869 -5,60 3,46 -29.318 494.112
2015-07-28 2015-07-24 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
X - Other 22.210 151.346 17,20 1,32 29.317 199.777
2015-06-22 2015-06-18 4 CORT CORCEPT THERAPEUTICS INC
Stock option
A - Award -70.000 70.000 -50,00
2015-06-22 3 CORT CORCEPT THERAPEUTICS INC
No securities are beneficially owned
0
2015-06-12 2015-06-10 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 37.500 37.500
2015-03-02 2015-02-27 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
F - Taxes -12.274 175.824 -6,53 2,22 -27.248 390.329
2015-03-02 2015-02-27 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
A - Award 30.330 188.098 19,22
2014-11-03 2014-10-31 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 300.000 300.000
2014-08-29 2014-08-27 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (right to buy)
M - Exercise -5.000 710.611 -0,70
2014-08-29 2014-08-27 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
S - Sale X -5.000 154.073 -3,14 8,00 -40.000 1.232.584
2014-08-29 2014-08-27 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
M - Exercise 5.000 159.073 3,25 2,09 10.450 332.463
2014-07-11 2014-06-11 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 54.750 54.750
2014-05-19 2014-05-16 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Optioon (Right to Buy)
M - Exercise -24.389 715.611 -3,30
2014-05-19 2014-05-16 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
M - Exercise 24.389 152.406 19,05 2,09 50.973 318.529
2014-03-04 2024-02-28 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
F - Taxes -3.747 128.017 -2,84 6,55 -24.543 838.511
2014-03-04 2014-02-28 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option Right to Buy
A - Award 300.000 300.000
2014-03-04 2014-02-28 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
A - Award 9.971 131.764 8,19 6,55 65.310 863.054
2013-06-19 2013-06-18 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -10.000 740.000 -1,33
2013-06-19 2013-06-18 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
M - Exercise -15.000 110.000 -12,00
2013-06-19 2013-06-18 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
M - Exercise 10.000 122.093 8,92 2,09 20.900 255.174
2013-06-19 2013-06-18 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
M - Exercise 15.000 112.093 15,45 2,94 44.100 329.553
2013-03-01 2013-02-28 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 300.000 300.000
2013-03-01 2013-02-28 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
F - Taxes -7.623 94.122 -7,49 5,22 -39.792 491.317
2013-03-01 2013-02-28 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
A - Award 20.785 101.745 25,67
2013-01-04 2013-01-02 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 25.000 25.000
2012-03-02 2012-02-29 4 SNSS SUNESIS PHARMACEUTICALS INC
Stock Option (Right to Buy)
A - Award 425.000 425.000
2012-03-02 2012-02-29 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
F - Taxes 20.226 74.522 37,25 1,74 35.193 129.668
2012-03-02 2012-02-29 4 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
A - Award 55.143 94.748 139,23
2012-01-06 2012-01-03 4 CERS CERUS CORP
Option (Right to Buy)
A - Award 12.877 12.877
2005-09-27 3 SNSS SUNESIS PHARMACEUTICALS INC
Common Stock
50.000
P
Åbent marked eller privat køb af ikke-afledte eller afledte værdipapirer
S
Åbent marked eller privat salg af ikke-afledte eller afledte værdipapirer
A
Tildeling, tildeling eller anden erhvervelse af værdipapirer fra virksomheden (såsom en option)
C
Konvertering af derivat
D
Salg eller overførsel af værdipapirer tilbage til virksomheden
F
Betaling af udnyttelseskurs eller skatteforpligtelse ved brug af en del af værdipapirer modtaget fra selskabet
G
Gave af værdipapirer af eller til insideren
K
Aktieswaps og lignende sikringstransaktioner
M
Udnyttelse eller konvertering af afledt værdipapir modtaget fra virksomheden (såsom en option)
V
En transaktion rapporteret frivilligt på formular 4
J
Andet (ledsaget af en fodnote, der beskriver transaktionen)